ILLUMINA INC (ILMN) Fundamental Analysis & Valuation
NASDAQ:ILMN • US4523271090
Current stock price
127.38 USD
+0.75 (+0.59%)
At close:
127.38 USD
0 (0%)
After Hours:
This ILMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ILMN Profitability Analysis
1.1 Basic Checks
- In the past year ILMN was profitable.
- ILMN had a positive operating cash flow in the past year.
- In multiple years ILMN reported negative net income over the last 5 years.
- Each year in the past 5 years ILMN had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of ILMN (12.79%) is better than 96.43% of its industry peers.
- The Return On Equity of ILMN (31.22%) is better than 98.21% of its industry peers.
- ILMN has a better Return On Invested Capital (13.63%) than 92.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.79% | ||
| ROE | 31.22% | ||
| ROIC | 13.63% |
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 19.57%, ILMN belongs to the top of the industry, outperforming 91.07% of the companies in the same industry.
- In the last couple of years the Profit Margin of ILMN has remained more or less at the same level.
- The Operating Margin of ILMN (20.29%) is better than 85.71% of its industry peers.
- ILMN's Operating Margin has improved in the last couple of years.
- ILMN has a better Gross Margin (66.61%) than 89.29% of its industry peers.
- ILMN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.29% | ||
| PM (TTM) | 19.57% | ||
| GM | 66.61% |
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
2. ILMN Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ILMN is still creating some value.
- Compared to 1 year ago, ILMN has less shares outstanding
- The number of shares outstanding for ILMN has been increased compared to 5 years ago.
- ILMN has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.30 indicates that ILMN is not in any danger for bankruptcy at the moment.
- ILMN's Altman-Z score of 4.30 is amongst the best of the industry. ILMN outperforms 80.36% of its industry peers.
- The Debt to FCF ratio of ILMN is 2.14, which is a good value as it means it would take ILMN, 2.14 years of fcf income to pay off all of its debts.
- ILMN has a better Debt to FCF ratio (2.14) than 89.29% of its industry peers.
- ILMN has a Debt/Equity ratio of 0.55. This is a neutral value indicating ILMN is somewhat dependend on debt financing.
- ILMN has a Debt to Equity ratio of 0.55. This is in the lower half of the industry: ILMN underperforms 64.29% of its industry peers.
- Even though the debt/equity ratio score it not favorable for ILMN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 2.14 | ||
| Altman-Z | 4.3 |
ROIC/WACC1.27
WACC10.75%
2.3 Liquidity
- A Current Ratio of 2.08 indicates that ILMN has no problem at all paying its short term obligations.
- ILMN's Current ratio of 2.08 is in line compared to the rest of the industry. ILMN outperforms 41.07% of its industry peers.
- ILMN has a Quick Ratio of 1.72. This is a normal value and indicates that ILMN is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of ILMN (1.72) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.72 |
3. ILMN Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 97.96% over the past year.
- Measured over the past 5 years, ILMN shows a small growth in Earnings Per Share. The EPS has been growing by 1.51% on average per year.
- ILMN shows a decrease in Revenue. In the last year, the revenue decreased by -0.66%.
- Measured over the past years, ILMN shows a small growth in Revenue. The Revenue has been growing by 6.04% on average per year.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
3.2 Future
- ILMN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.73% yearly.
- ILMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.80% yearly.
EPS Next Y7.88%
EPS Next 2Y10.79%
EPS Next 3Y11.43%
EPS Next 5Y11.73%
Revenue Next Year5.76%
Revenue Next 2Y5.62%
Revenue Next 3Y5.85%
Revenue Next 5Y5.8%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. ILMN Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 26.26, ILMN can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, ILMN is valued a bit cheaper than 73.21% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 25.60. ILMN is around the same levels.
- Based on the Price/Forward Earnings ratio of 24.35, the valuation of ILMN can be described as rather expensive.
- 69.64% of the companies in the same industry are more expensive than ILMN, based on the Price/Forward Earnings ratio.
- ILMN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.26 | ||
| Fwd PE | 24.35 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ILMN is valued a bit cheaper than 78.57% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ILMN indicates a rather cheap valuation: ILMN is cheaper than 82.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.92 | ||
| EV/EBITDA | 17.04 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of ILMN may justify a higher PE ratio.
PEG (NY)3.33
PEG (5Y)17.4
EPS Next 2Y10.79%
EPS Next 3Y11.43%
5. ILMN Dividend Analysis
5.1 Amount
- No dividends for ILMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ILMN Fundamentals: All Metrics, Ratios and Statistics
127.38
+0.75 (+0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)05-06 2026-05-06/amc
Inst Owners105.54%
Inst Owner Change-0.87%
Ins Owners0.17%
Ins Owner Change3.08%
Market Cap19.48B
Revenue(TTM)4.34B
Net Income(TTM)850.00M
Analysts73.57
Price Target139.02 (9.14%)
Short Float %4.74%
Short Ratio3.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.14%
Min EPS beat(2)7.62%
Max EPS beat(2)12.65%
EPS beat(4)4
Avg EPS beat(4)9.22%
Min EPS beat(4)1.33%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)14.29%
EPS beat(12)10
Avg EPS beat(12)229.93%
EPS beat(16)13
Avg EPS beat(16)175.4%
Revenue beat(2)1
Avg Revenue beat(2)1.24%
Min Revenue beat(2)-0.28%
Max Revenue beat(2)2.75%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)2.75%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.28%
Revenue beat(16)5
Avg Revenue beat(16)-0.88%
PT rev (1m)0.43%
PT rev (3m)10.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.96%
EPS NY rev (1m)1.06%
EPS NY rev (3m)2.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.77%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)3.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.26 | ||
| Fwd PE | 24.35 | ||
| P/S | 4.48 | ||
| P/FCF | 20.92 | ||
| P/OCF | 18.05 | ||
| P/B | 7.15 | ||
| P/tB | 13.91 | ||
| EV/EBITDA | 17.04 |
EPS(TTM)4.85
EY3.81%
EPS(NY)5.23
Fwd EY4.11%
FCF(TTM)6.09
FCFY4.78%
OCF(TTM)7.06
OCFY5.54%
SpS28.4
BVpS17.81
TBVpS9.16
PEG (NY)3.33
PEG (5Y)17.4
Graham Number44.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.79% | ||
| ROE | 31.22% | ||
| ROCE | 17.41% | ||
| ROIC | 13.63% | ||
| ROICexc | 20.13% | ||
| ROICexgc | 32.79% | ||
| OM | 20.29% | ||
| PM (TTM) | 19.57% | ||
| GM | 66.61% | ||
| FCFM | 21.44% |
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y1.94%
ROICexgc growth 5Y5.2%
ROICexc growth 3Y74.03%
ROICexc growth 5Y4.4%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
F-Score8
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 2.14 | ||
| Debt/EBITDA | 1.29 | ||
| Cap/Depr | 54.81% | ||
| Cap/Sales | 3.41% | ||
| Interest Coverage | 9.27 | ||
| Cash Conversion | 93.74% | ||
| Profit Quality | 109.53% | ||
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.72 | ||
| Altman-Z | 4.3 |
F-Score8
WACC10.75%
ROIC/WACC1.27
Cap/Depr(3y)45.45%
Cap/Depr(5y)67.5%
Cap/Sales(3y)3.56%
Cap/Sales(5y)5.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y7.88%
EPS Next 2Y10.79%
EPS Next 3Y11.43%
EPS Next 5Y11.73%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
Revenue Next Year5.76%
Revenue Next 2Y5.62%
Revenue Next 3Y5.85%
Revenue Next 5Y5.8%
EBIT growth 1Y36.38%
EBIT growth 3Y34.38%
EBIT growth 5Y8.17%
EBIT Next Year32.05%
EBIT Next 3Y17.05%
EBIT Next 5Y16.57%
FCF growth 1Y31.31%
FCF growth 3YN/A
FCF growth 5Y0.88%
OCF growth 1Y28.91%
OCF growth 3Y40.15%
OCF growth 5Y-0.02%
ILLUMINA INC / ILMN Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ILLUMINA INC?
ChartMill assigns a fundamental rating of 6 / 10 to ILMN.
Can you provide the valuation status for ILLUMINA INC?
ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (ILMN). This can be considered as Fairly Valued.
Can you provide the profitability details for ILLUMINA INC?
ILLUMINA INC (ILMN) has a profitability rating of 7 / 10.
What is the valuation of ILLUMINA INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ILLUMINA INC (ILMN) is 26.26 and the Price/Book (PB) ratio is 7.15.
What is the earnings growth outlook for ILLUMINA INC?
The Earnings per Share (EPS) of ILLUMINA INC (ILMN) is expected to grow by 7.88% in the next year.